Great Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 4.00 M
- Revenue Growth 49.39%
- Profit Growth 47.04%
- Ebitda 35.80%
- Net Worth 135.59%
- Total Assets 41.75%
About Great Lifesciences
Great Lifesciences Private Limited (GLPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 February 2014 and has a history of Ten years and 11 months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.00 M.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100GJ2014PTC078948
-
Company No.
078948
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Feb 2014
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Great Lifesciences Private Limited offer?
Great Lifesciences Private Limited offers a wide range of products and services, including .
Who are the key members and board of directors at Great Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gunjan Mishra
|
Director | 28-Feb-2014 | Current |
|
Suryaprakash Tiwari
|
Director | 09-Aug-2021 | Current |
Financial Performance of Great Lifesciences.
Great Lifesciences Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 49.39% increase. The company also saw a substantial improvement in profitability, with a 47.04% increase in profit. The company's net worth Soared by an impressive increase of 135.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Great Lifesciences?
In 2020, Great Lifesciences had a promoter holding of 92.50% and a public holding of 7.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹4.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Feb 2015 | Others | ₹4.00 M | Open |
How Many Employees Work at Great Lifesciences?
Great Lifesciences has a workforce of 2 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Great Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Great Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
